Breaking News: FDA Approves Roche’s Revolutionary Test for Detecting B-Cell Lymphoma Description: The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma subtypes. The test helps differentiate a B-cell
Calling All PACS Investors: Take Action Against Securities Fraud with The Schall Law Firm! Introduction LOS ANGELES, Jan. 12, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, has announced the filing of a class action lawsuit against PACS Group, Inc. (“PACS” or “the Company”) (NYSE:
Attention Shareholders: Don’t Miss Out on Potential Compensation A Reminder from Pomerantz Law Firm Regarding Aehr Test Systems, Inc. Class Action Lawsuit and Upcoming Deadlines! Attention all shareholders of Aehr Test Systems, Inc. – If you purchased or acquired securities of Aehr between January 9, 2024, and March 24, 2024,
Uncovering Potential Securities Fraud: A Closer Look into Sangamo Therapeutics Inc. (SGMO) by Levi Korsinsky NEW YORK, NY / ACCESSWIRE / January 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Sangamo Therapeutics, Inc. (“Sangamo Therapeutics, Inc.”) (NASDAQ:SGMO) concerning possible violations of federal securities
Attention Investors: Important Update on Kyverna Therapeutics Inc. Class Action Lawsuit – Don’t Miss the February 7, 2025 Deadline! New York, NY / ACCESSWIRE / January 12, 2025 Introduction: If you are an investor who has suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment, you may be entitled
Step into Style: Why Crocs May Have Finally Hit Their Stride Introduction Crocs, the iconic brand known for its comfortable, colorful clogs, has had its fair share of ups and downs over the years. However, recent indicators suggest that the company may be on the brink of a major turnaround.
Breaking News: Regeneron Pharmaceuticals Inc. Faces Legal Action for Securities Law Breaches – What Investors Need to Know The Schall Law Firm Alerts Investors of Class Action Lawsuit Against Regeneron Pharmaceuticals Inc. The legal world is buzzing with the recent announcement of a class action lawsuit against Regeneron Pharmaceuticals, Inc.
Unleashing the Potential: Top Cannabis Stocks to Keep an Eye on in 2025 and Expert Trading Tips The Current State of the Cannabis Industry The cannabis sector has faced significant turbulence in 2025, with recent legislative developments in Florida creating a noticeable pullback. Florida voters rejected Amendment 3, which sought
Breaking News: The Swiss Helvetia Fund Calls for Special Meeting in 2025! New York, Jan. 10, 2025 (GLOBE NEWSWIRE) — The Swiss Helvetia Fund, Inc. (the “Fund”) (NYSE: SWZ) announced today that it has filed preliminary proxy materials with the Securities and Exchange Commission (the “SEC”) in connection with a
Mark Your Calendars: TrustCo’s Fourth Quarter 2024 Results to be Unveiled on January 21, 2025 with Conference Call on January 22, 2025! Exciting News Alert! GLENVILLE, N.Y., Jan. 10, 2025 (GLOBE NEWSWIRE) — TrustCo Bank Corp NY (TrustCo, Nasdaq: TRST) today announced that it will release fourth quarter 2024 results
Nokia Buys Back Its Own Shares – A Bold Move for the Future! Nokia Corporation Stock Exchange Release 10 January 2025 at 22:30 EET Nokia Corporation: Repurchase of own shares on 10.01.2025 Espoo, Finland – On 10 January 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681)
Super Bowl LIX: The Ultimate Showdown Between Peyton and Eli Manning in FanDuel’s Kick of Destiny 3 Campaign Description: FanDuel customers can make a free pick in the FanDuel Sportsbook app on which Manning they think will win a live field goal competition for a chance to win a share
Mark Your Calendars: Omega’s Q4 Earnings Release and Conference Call Date Revealed! HUNT VALLEY, Md.–(BUSINESS WIRE)– Exciting News from Omega Healthcare Investors, Inc. Omega Healthcare Investors, Inc. (NYSE:OHI) has just announced that it will be releasing its earnings results for the fourth quarter ended December 31, 2024, on Wednesday, February
Bottoms Up: A Recap of Constellation Brands’ Q3 2025 Earnings Call Description: Constellation Brands, Inc. (NYSE:STZ ) Q3 2025 Earnings Conference Call took place on January 10, 2024 at 10:30 AM ET. The call featured key company executives and various conference call participants from leading financial institutions. Introduction: Welcome to
Breaking News: Virbac Reveals Share and Voting Numbers for 2025! DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés
Breaking News: Kessler Topaz Meltzer Check LLP Takes Action Against MGP Ingredients Inc. for Securities Fraud Description: RADNOR, Pa., Jan. 10, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed in the United States
Risk Disclaimer: Sigmanomics is a financial portal that provides news and analysis about the different financial markets. The articles that we serve on the portal depend solely on the opinion and analysis of our economists which in no way are intended to incite a visitor of the website or an investor to trade or sell/buy a certain instrument. It is the responsibility of the visitor / trader only to evaluate his trading strategies and whether he is capable of trading with taking into consideration that losing all the capital invested is a possibility. The visitor should seek an independent professional financial advisor to discuss his or her trading strategies. Moreover, the provided rates for the different instruments are indicative only and cannot be used for trading purposes. Therefore, no responsibility can be imposed on sigmanomics.com.com and the company operating the portal for any loss of money that may occur to the visitor by using the website.
